Related Experiment Video
Updated: Aug 24, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Implications of the Systolic Hypertension in China trial
1Hypertension Division, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing.
Insights
Antihypertensive treatment significantly reduces stroke and cardiovascular events in older Chinese adults with isolated systolic hypertension. This intervention offers substantial prevention of deaths, strokes, and major cardiovascular endpoints.
Area of Science:
- Cardiology
- Geriatrics
- Public Health
Background:
- Isolated systolic hypertension is a significant risk factor for cardiovascular complications in older populations.
- The Systolic Hypertension in China (Syst-China) study aimed to address this prevalent condition.
Purpose of the Study:
- To investigate the efficacy of active antihypertensive treatment in reducing stroke and cardiovascular complications.
- To evaluate the impact of specific drug regimens on cardiovascular outcomes in elderly Chinese patients.
Main Methods:
- A randomized controlled trial involving 1253 patients assigned active treatment (nitrendipine, captopril, hydrochlorothiazide) and 1141 controls receiving placebos.
- Patients were stratified by center, sex, and prior cardiovascular complications.
- Treatment involved nitrendipine with optional addition of captopril and/or hydrochlorothiazide.
Main Results:
- Active treatment resulted in a significant reduction in systolic blood pressure by 9.1 mm Hg and diastolic by 3.2 mm Hg over 2 years.
- Total stroke incidence decreased by 38%, all-cause mortality by 39%, and cardiovascular mortality by 39%.
- Significant reductions were observed in stroke mortality (58%) and combined fatal/nonfatal cardiovascular endpoints (37%).
Conclusions:
- Antihypertensive therapy is effective in preventing stroke and other cardiovascular complications in elderly Chinese patients with isolated systolic hypertension.
- Long-term treatment could lead to substantial public health benefits, preventing numerous deaths and cardiovascular events.
- The findings support the implementation of antihypertensive treatment strategies for this demographic.
Abstract:
In 1988, the Systolic Hypertension in China (Syst-China) Collaborative Group started to investigate whether active treatment could reduce the incidence of stroke and other cardiovascular complications of isolated systolic hypertension. After stratification for center, sex and previous cardiovascular complications, alternate patients (n = 1253) were assigned nitrendipine 10-40 mg daily, with the possible addition of captopril 12.5-50.0 mg daily, or hydrochlorothiazide 12.5-50.0 mg daily, or both drugs. In 1141 control patients, matching placebos were employed similarly. At entry, sitting blood pressure averaged 170 mm Hg systolic and 86 mm Hg diastolic, age averaged 66 years, and total serum cholesterol was 5.1 mmol/L. At 2 years, the between-group differences were 9.1 mm Hg systolic (95% confidence interval: 7.6-10.7 mm Hg) and 3.2 mm Hg diastolic (2.4-4.0). Active treatment reduced total stroke by 38% (p=0.01), all-cause mortality by 39% (p=0.003), cardiovascular mortality by 39% (p=0.03), stroke mortality by 58% (p=0.02) and all fatal and nonfatal cardiovascular endpoints by 37% (p=0.004). In conclusion, antihypertensive treatment prevents stroke and other cardiovascular complications in older Chinese patients with isolated systolic hypertension. Treatment of 1000 Chinese patients for 5 years could prevent 55 deaths, 39 strokes, or 59 major cardiovascular endpoints.
More Related Videos
Related Concept Videos
Errors occurring during blood pressure monitoring
Several factors...
Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies

